Testing Pathway

Testing is recommended at initial visit, every 6 to 12 months for patients with low Vectra scores, and every 3 months for patients with high Vectra scores until their RA is in the moderate or low range.

This pathway can provide patients with better outcomes through improved communication, timely evaluation of treatment response, stratification of patients for risk of radiographic progression and assistance with medical management decisions.

Patient Testing Pathway
Vectra Intended Use
Management Decision
Therapy Monitoring
Low Activity Monitoring
Phlebotomy Options

Phlebotomists can draw and prepare specimen for shipping using provided kits. No reimbursement will be made for specimens collected via in-office phlebotomists.

Contracted 3rd Party Laboratory Services
Contracted 3rd Party Laboratory Services

We work with 3rd party laboratories (e.g. LabCorp) to make Vectra easily accessible for patients

Contact Vectra Customer Service, 1-877-743-8639, to request one or more of the following: a customized Test Requisition Form (TRF), a Vectra Specimen Processing Kit with a pre-paid return label, or for assistance locating a contracted 3rd party laboratory service.


Newsletter Signup


Vectra Clinical Data
Vectra Cardiovascular Risk Clinical Data

Order Vectra Test